Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics

US firm Cimphoni launches medical device business

MDBR Staff Writer Published 29 January 2016

US-based Cimphoni has launched a new business, which will involve in the development of novel medical devices and solutions.

Cimphoni

The new business, Cimphoni Life Sciences, will use engineers, industrial designers, physicians and research staff to convert laboratory research and clinical discoveries into medical devices.

Cimphoni Life Sciences is partnering with the Medical College of Wisconsin to develop medical solutions to be used in the diagnosis, treatment and prevention of both acute and chronic illnesses.

The partnership will initially focus on developing devices and treatments for osteoporosis and fracture healing, as well as immunochromatographic assays for the diagnosis of periprosthetic joint infections.

The collaboration will also develop solutions by using nano-scale technology, which can be used in the in vivo diagnosis of periprosthetic joint infections.

Cimphoni president and CEO Rick Davidson said: "We're excited to expand our services into the life sciences sector where we can create next generation medical technologies and devices.

"Our capability to develop innovative medical devices is made even stronger through our business partnership with the Medical College of Wisconsin."

"Imagine the possibilities when world-class physicians and medical researchers combine their knowledge and expertise with both engineers and technology experts to drive innovation in completely new directions."


Image: Cimphoni Life Sciences will develop devices and treatments for osteoporosis, fracture healing and joint infections. Photo: courtesy of PRNewsFoto / Cimphoni.